Home » Newsletters » BioWorld Asia

BioWorld Asia

March 1, 2000

View Archived Issues

Oxford GlycoSciences Pushes Proteomics With $52M Funding

Patent On Transgenic Stem Cells Causes Furor In Europe

EU Technical Work Continues Despite Doubts Around Biotech

KS Biomedix Raises $24.5M As It Prepares For Phase III

Antibiotic Use Must Decrease To Remove Resistant Bacteria

Israeli Group Plans Studies Of Cancer Sensitivity Test In China

Strathmann Plans To Develop Therapeutics For HIV, Cancer

EuropaBio Gets Support From Scientists On GM Foods Issue

Euro Commission Takes Neutral Stance On Genetic Technologies

European Pharma Industry Opposes Liability Extensions

Genset Reports Increase Of 50 Percent In Loss For 1999

Other News To Note

Kamada, Red Cross Collaborate On Plasma Therapeutic Product

Appligene Takes Majority Position In Excell Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...